Skip to main content

Table 2 Factors associated with IPROS

From: Immediate pressor response to oral salt and its assessment in the clinic: a time series clinical trial

Variable

IPROS

responders

n = 79 (62%)

IPROS

nonresponders

n = 48 (38%)

P-value

Age (yr)

29 (22–46)

31 (23–47)

0.707

Sex

 Male

38 (48.1)

23 (47.9)

0.594

 Female

41 (51.9)

25 (52.1)

 

Employment status (n = 125)

 Employed

14 (17.9)

10 (21.3)

0.899

 Unemployed

59 (75.6)

34 (72.3)

 

 Retired

5 (6.4)

3 (6.4)

 

Marital status (n = 125)

 Married

25 (32.1)

21 (44.7)

0.416

 Single

43 (55.1)

23 (48.9)

 

 Divorced/separated

5 (6.4)

2 (4.3)

 

 Widowed

5 (6.4)

1 (2.1)

 

HIV status (n = 125)

 Negative

62 (79.5)

38 (80.9)

0.854

 Positive

16 (20.5)

9 (19.1)

 

Body mass index (kg/m2)

23.4 (21.0–26.3)

23.0 (20.3–28.2)

0.933

Ankle brachial index category (n = 125)

 Normal

74 (94.9)

45 (95.7)

0.790

 Peripheral artery disease

4 (5.1)

2 (4.3)

 

Pulse pressure (mmHg)

2 (−6 to 11)

0 (−7 to 5)

0.040

Fasting blood sugar (mmol/L)

4.7 (4.2–5.1)

4.7 (4.2–5.0)

0.746

Erythrocyte sodium sensitive (n = 117)

 Low (< 80%)

11 (8.9)

4 (15.3)

0.004

 Average (80–120%)

23 (8.9)

4 (31.9)

 

 High (>  120%)

38 (82.2)

37 (52.8)

 
  1. Data are presented as median (interquartile range) or number (%)
  2. IPROS Immediate pressor response to oral salt, HIV Human immunodeficiency virus